Cargando…
The cost‐effectiveness of real‐time pulmonary artery pressure monitoring in heart failure patients: a European perspective
AIMS: Heart failure (HF) treatment guided by physicians with access to real‐time pressure measurement from a wireless implantable pulmonary artery pressure (PAP) sensor (CardioMEMS), has previously been shown to reduce HF‐related hospital admissions in the CHAMPION trial. However, uncertainty remain...
Autores principales: | Cowie, Martin R., Simon, Marcus, Klein, Liviu, Thokala, Praveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434803/ https://www.ncbi.nlm.nih.gov/pubmed/28176424 http://dx.doi.org/10.1002/ejhf.747 |
Ejemplares similares
-
Pulmonary artery pressure‐guided heart failure management: US cost‐effectiveness analyses using the results of the CHAMPION clinical trial
por: Martinson, Melissa, et al.
Publicado: (2016) -
Real‐time pulmonary artery pressure monitoring in heart failure patients: an updated cost‐effectiveness analysis
por: Cowie, Martin R., et al.
Publicado: (2023) -
Predictors of primary prevention implantable cardioverter‐defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all‐cause mortality
por: Schrage, Benedikt, et al.
Publicado: (2022) -
Assessment of Association Between Venous Occlusion and Infection of Cardiac Implantable Electronic Devices
por: Keyser, Andreas, et al.
Publicado: (2021) -
Validation of the Somnotouch-NIBP noninvasive continuous blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010
por: Bilo, Grzegorz, et al.
Publicado: (2015)